MICHELLE LUDWIG

Concepts (201)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
12
2024
237
4.080
Why?
Brachytherapy
8
2024
75
2.980
Why?
Radiosurgery
4
2020
111
1.910
Why?
Genital Neoplasms, Female
2
2024
46
1.450
Why?
Breast Neoplasms
5
2021
2518
1.040
Why?
Neoplasms
5
2022
2794
1.030
Why?
Radiation Injuries
3
2019
143
0.980
Why?
Radiotherapy
5
2020
138
0.920
Why?
Radiotherapy, Intensity-Modulated
3
2024
70
0.890
Why?
Carcinoma, Squamous Cell
2
2020
669
0.880
Why?
Radiation Oncology
1
2022
23
0.800
Why?
Cultural Diversity
1
2022
63
0.780
Why?
Precision Medicine
1
2024
321
0.710
Why?
Radiotherapy Dosage
3
2020
187
0.700
Why?
Pain, Procedural
1
2020
8
0.690
Why?
Thyroid Neoplasms
2
2019
189
0.680
Why?
Occupational Injuries
1
2020
9
0.670
Why?
Musculoskeletal System
1
2020
18
0.670
Why?
Anesthesia, Local
1
2020
44
0.670
Why?
Anesthesia, Obstetrical
1
2020
33
0.670
Why?
Ambulatory Surgical Procedures
1
2020
55
0.660
Why?
Adenocarcinoma
2
2018
1023
0.640
Why?
Neoplasms, Radiation-Induced
1
2019
81
0.640
Why?
Allied Health Personnel
1
2020
72
0.630
Why?
Analgesics
1
2020
127
0.630
Why?
Carcinoma, Small Cell
1
2019
51
0.630
Why?
Endometrial Neoplasms
1
2020
99
0.620
Why?
Triple Negative Breast Neoplasms
1
2021
234
0.610
Why?
Hydrocodone
1
2018
32
0.590
Why?
Codeine
1
2018
22
0.590
Why?
Clinical Trials as Topic
1
2022
1095
0.580
Why?
Hormones
1
2019
186
0.580
Why?
Neoplasms, Second Primary
1
2019
146
0.580
Why?
Neoplasm Staging
8
2022
1275
0.570
Why?
Lung Injury
1
2019
121
0.560
Why?
Acetaminophen
1
2018
93
0.550
Why?
Healthcare Disparities
2
2018
439
0.530
Why?
Metabolic Syndrome
1
2020
342
0.520
Why?
Chemoradiotherapy
5
2022
104
0.520
Why?
Colonic Neoplasms
1
2019
248
0.520
Why?
Female
28
2024
66704
0.500
Why?
Radiotherapy Planning, Computer-Assisted
3
2024
63
0.460
Why?
Androgen Antagonists
1
2015
120
0.450
Why?
Head and Neck Neoplasms
1
2019
503
0.440
Why?
Humans
35
2024
125110
0.440
Why?
Databases, Factual
4
2020
1172
0.440
Why?
Prostate-Specific Antigen
1
2015
255
0.430
Why?
Quality of Life
2
2022
1906
0.430
Why?
United States
9
2022
10884
0.420
Why?
Delivery of Health Care
1
2018
615
0.400
Why?
Middle Aged
13
2024
26676
0.380
Why?
Aged
9
2020
19656
0.370
Why?
SEER Program
3
2020
202
0.360
Why?
Adult
12
2024
29460
0.360
Why?
Patient Positioning
1
2010
55
0.320
Why?
Brain Neoplasms
1
2018
1316
0.310
Why?
Safety-net Providers
2
2022
51
0.310
Why?
Skin
2
2019
520
0.300
Why?
Neoadjuvant Therapy
2
2021
344
0.290
Why?
Family Planning Services
2
2024
37
0.280
Why?
Retrospective Studies
8
2020
16338
0.270
Why?
Propensity Score
2
2018
221
0.270
Why?
Prostatic Neoplasms
1
2015
1550
0.250
Why?
Survival Rate
3
2020
2051
0.250
Why?
Young Adult
5
2019
9056
0.250
Why?
Socioeconomic Factors
2
2018
858
0.240
Why?
Lymph Node Excision
1
2005
165
0.230
Why?
Aged, 80 and over
3
2020
6537
0.220
Why?
Physicians, Women
1
2024
46
0.220
Why?
Lymph Nodes
1
2005
378
0.210
Why?
Patient Compliance
2
2017
470
0.210
Why?
Treatment Adherence and Compliance
1
2022
11
0.200
Why?
Neoplasm Recurrence, Local
2
2019
1155
0.200
Why?
Oncologists
1
2022
28
0.200
Why?
Anthracyclines
1
2021
37
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
348
0.190
Why?
Infertility
1
2022
77
0.190
Why?
Positron-Emission Tomography
2
2024
306
0.180
Why?
Cisplatin
2
2020
250
0.180
Why?
Urban Population
1
2022
228
0.180
Why?
Age Factors
3
2019
2815
0.180
Why?
Minority Groups
1
2022
243
0.170
Why?
Promethazine
1
2020
5
0.170
Why?
Hydromorphone
1
2020
11
0.170
Why?
Lorazepam
1
2020
12
0.170
Why?
Organs at Risk
1
2020
24
0.170
Why?
Antiemetics
1
2020
22
0.170
Why?
Ibuprofen
1
2020
40
0.170
Why?
Emotions
1
2022
348
0.160
Why?
Rectum
1
2020
99
0.160
Why?
Anti-Anxiety Agents
1
2020
74
0.160
Why?
Radiodermatitis
1
2019
7
0.160
Why?
Survival Analysis
2
2018
1496
0.160
Why?
Radiation Pneumonitis
1
2019
12
0.160
Why?
Administration, Topical
1
2019
138
0.160
Why?
Esomeprazole
1
2019
32
0.160
Why?
Mastectomy, Radical
1
2019
8
0.160
Why?
Disease-Free Survival
3
2017
880
0.160
Why?
Urinary Bladder
1
2020
242
0.160
Why?
Chernobyl Nuclear Accident
1
2018
6
0.150
Why?
Drug Therapy
1
2019
87
0.150
Why?
Radiotherapy, Image-Guided
1
2018
15
0.150
Why?
Carcinoma, Neuroendocrine
1
2018
33
0.150
Why?
Cranial Irradiation
1
2018
69
0.150
Why?
Tomography, X-Ray Computed
3
2024
2093
0.150
Why?
Radiation Exposure
1
2018
42
0.150
Why?
Pulmonary Fibrosis
1
2019
109
0.140
Why?
Chemotherapy, Adjuvant
1
2019
366
0.140
Why?
Drug Combinations
1
2018
262
0.140
Why?
Fibrosis
1
2019
442
0.140
Why?
General Surgery
1
2019
204
0.140
Why?
Medicare
1
2020
427
0.130
Why?
Male
8
2020
61443
0.130
Why?
Surveys and Questionnaires
3
2024
3675
0.130
Why?
Neoplasm Metastasis
1
2019
705
0.130
Why?
Survivors
1
2018
339
0.130
Why?
Biomarkers, Tumor
1
2024
1534
0.130
Why?
Neoplasm Invasiveness
1
2018
625
0.130
Why?
Logistic Models
2
2018
1800
0.120
Why?
Combined Modality Therapy
1
2019
1237
0.120
Why?
Lung Neoplasms
1
2005
1654
0.120
Why?
Treatment Outcome
4
2018
12272
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2015
63
0.120
Why?
Biopsy
1
2019
1242
0.120
Why?
Carcinoma, Ductal, Breast
1
2015
85
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1245
0.110
Why?
Mastectomy, Segmental
2
2015
27
0.110
Why?
Radiography
2
2022
802
0.110
Why?
Neoplasm Grading
1
2015
276
0.110
Why?
Prevalence
1
2020
2458
0.110
Why?
Age of Onset
1
2015
600
0.100
Why?
Antineoplastic Agents
2
2020
1714
0.100
Why?
Infusion Pumps, Implantable
1
2013
40
0.100
Why?
Carcinoma
1
2015
289
0.100
Why?
Pandemics
1
2020
1112
0.100
Why?
Internship and Residency
1
2022
1178
0.100
Why?
Inflammation
1
2019
1447
0.100
Why?
Prospective Studies
1
2022
6123
0.090
Why?
Proportional Hazards Models
1
2015
1361
0.090
Why?
Fertility
2
2024
257
0.090
Why?
Cohort Studies
1
2020
4821
0.090
Why?
Image Processing, Computer-Assisted
1
2013
586
0.080
Why?
Risk Assessment
1
2019
3424
0.080
Why?
Electrons
1
2010
24
0.080
Why?
Pain
1
2013
447
0.080
Why?
Prognosis
1
2019
4683
0.080
Why?
Texas
1
2018
3571
0.080
Why?
Analgesics, Opioid
1
2013
409
0.080
Why?
Risk Factors
2
2020
10278
0.070
Why?
Brain
1
2018
3014
0.070
Why?
Pulmonary Disease, Chronic Obstructive
1
2013
604
0.060
Why?
Child
3
2022
24609
0.060
Why?
Adolescent
2
2019
19414
0.060
Why?
Postoperative Period
1
2005
333
0.060
Why?
Infant
1
2019
12609
0.060
Why?
Sexism
1
2024
38
0.060
Why?
Pneumonectomy
1
2005
144
0.050
Why?
Child, Preschool
1
2019
14151
0.050
Why?
Body Mass Index
1
2010
1563
0.050
Why?
Positron Emission Tomography Computed Tomography
1
2024
76
0.050
Why?
Diffusion Magnetic Resonance Imaging
1
2024
142
0.050
Why?
Medical Oncology
1
2024
220
0.050
Why?
Cystoscopy
1
2022
44
0.050
Why?
Magnetic Resonance Imaging
2
2024
3600
0.050
Why?
Consensus
1
2024
645
0.050
Why?
Ultrasonography, Interventional
1
2021
189
0.040
Why?
Heme Oxygenase-1
1
2019
36
0.040
Why?
Active Transport, Cell Nucleus
1
2019
118
0.040
Why?
Multiple Endocrine Neoplasia Type 2a
1
2018
2
0.040
Why?
Multiple Endocrine Neoplasia Type 2b
1
2018
4
0.040
Why?
Proto-Oncogene Proteins c-ret
1
2018
23
0.040
Why?
Attitude of Health Personnel
1
2024
668
0.040
Why?
Models, Anatomic
1
2019
100
0.040
Why?
NF-E2-Related Factor 2
1
2019
114
0.040
Why?
Anti-Inflammatory Agents
1
2019
292
0.030
Why?
Germ-Line Mutation
1
2018
343
0.030
Why?
Wound Healing
1
2019
457
0.030
Why?
Time Factors
2
2015
6301
0.030
Why?
Radiotherapy, Adjuvant
1
2015
145
0.030
Why?
Algorithms
1
2022
1630
0.030
Why?
Kaplan-Meier Estimate
1
2017
1066
0.030
Why?
Chi-Square Distribution
1
2015
584
0.030
Why?
Academic Medical Centers
1
2015
308
0.030
Why?
Four-Dimensional Computed Tomography
1
2013
5
0.030
Why?
Infusions, Spinal
1
2013
2
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
887
0.030
Why?
Equipment Failure
1
2013
121
0.020
Why?
Sequence Analysis, DNA
1
2018
1762
0.020
Why?
Gene Expression Profiling
1
2019
1757
0.020
Why?
Odds Ratio
1
2015
1253
0.020
Why?
Reference Standards
1
2013
235
0.020
Why?
Multivariate Analysis
1
2015
1425
0.020
Why?
Membrane Proteins
1
2019
1538
0.020
Why?
Pain Management
1
2013
177
0.020
Why?
Mice, Inbred C57BL
1
2019
4417
0.020
Why?
Pregnancy
1
2022
7221
0.020
Why?
Disease Models, Animal
1
2019
4408
0.020
Why?
Severity of Illness Index
1
2015
2906
0.020
Why?
Follow-Up Studies
1
2015
5169
0.020
Why?
Mice
1
2019
17740
0.010
Why?
Animals
1
2019
34304
0.010
Why?
LUDWIG's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (201)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_